Recent discussions have sparked curiosity regarding Adele’s weight loss journey and the potential use of Ozempic, a medication primarily prescribed for type 2 diabetes but also noted for its weight loss effects. While the British pop diva has undergone a significant body transformation, attributing her weight loss to this drug remains speculative.
The singer has not publicly confirmed any use of Ozempic, and without direct confirmation, it is inappropriate to make such assumptions. However, this topic can serve to open the public debate on what Ozempic really is, what it is used for, its effects, and the celebrities who have shared their opinions on it.
Ozempic, generically known as semaglutide, is a glucagon-like peptide-1 (GLP-1) receptor agonist initially developed to manage blood sugar levels in individuals with type 2 diabetes. Beyond its primary use, it has gained attention for its side effect of promoting weight loss by suppressing appetite. This unintended benefit has led to its adoption, sometimes off-label, among various celebrities seeking to shed pounds.
Although it remains speculative to attribute the weight loss of celebrities like Adele or Lizzo to Ozempic, these rumors are actually due to the widespread use of the medication. From January 2021 to December 2023, the number of semaglutide prescriptions in the U.S. increased by 442%, rising from 471,876 to 2,555,308 fills. 70% of these are Ozempic prescriptions. This shift could gradually leave behind some of the inclusivity and body-positive standards established in recent years by figures like Lizzo or the Kardashians, making slimness more visible once again.
View this post on Instagram
The allure of rapid weight loss has led several public figures to address their use of Ozempic:
View this post on Instagram
View this post on Instagram
The trend of using Ozempic for weight loss has raised significant health concerns. Potential side effects include nausea, pancreatitis, and other gastrointestinal issues. Moreover, the misuse of such medications, especially without medical supervision, poses serious health risks. Experts caution against the non-prescribed use of GLP-1 receptor agonists, highlighting the importance of consulting healthcare professionals before starting any weight loss regimen.
©PRISA MEDIA USA, INC. All rights reserved.
PRISA MEDIA USA, INC, expressly reserves the right to reproduce and use the works and other services accessible from this website by machine-readable media or other suitable means.